18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is intended to assist health care professionals worldwide who evaluate and manage potential candidates for deceased or living donor kidney transplantation. This guideline addresses general candidacy issues such as access to transplantation, patient demographic and health status factors, and immunological and psychosocial assessment. The roles of various risk factors and comorbid conditions governing an individual's suitability for transplantation such as adherence, tobacco use, diabetes, obesity, perioperative issues, causes of kidney failure, infections, malignancy, pulmonary disease, cardiac and peripheral arterial disease, neurologic disease, gastrointestinal and liver disease, hematologic disease, and bone and mineral disorder are also addressed. This guideline provides recommendations for evaluation of individual aspects of a candidate's profile such that each risk factor and comorbidity are considered separately. The goal is to assist the clinical team to assimilate all data relevant to an individual, consider this within their local health context, and make an overall judgment on candidacy for transplantation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. Guideline recommendations are primarily based on systematic reviews of relevant studies and our assessment of the quality of that evidence, and the strengths of recommendations are provided. Limitations of the evidence are discussed with differences from previous guidelines noted and suggestions for future research are also provided.

          Related collections

          Author and article information

          Journal
          Transplantation
          Transplantation
          Springer Science and Business Media LLC
          1534-6080
          0041-1337
          Apr 2020
          : 104
          : 4S1 Suppl 1
          Affiliations
          [1 ] Royal Prince Alfred Hospital and Charles Perkins Centre, University of Sydney, Sydney, Australia.
          [2 ] Seoul National University, Seoul, South Korea.
          [3 ] University of Iowa, Iowa City, IA.
          [4 ] The Montreal Children's Hospital, McGill University Health Centre, Montreal, Canada.
          [5 ] Hennepin County Medical Center, Minneapolis, MN.
          [6 ] Medanta Kidney and Urology Institute, Haryana, India.
          [7 ] University Health Network, University of Toronto, Toronto, Canada.
          [8 ] Medical University of Vienna, Vienna, Austria.
          [9 ] Hospital del Mar, Barcelona, Spain.
          [10 ] Auckland City Hospital, Auckland, New Zealand.
          [11 ] Beth Israel Deaconess Medical Center, Boston, MA.
          [12 ] Johns Hopkins University School of Medicine, Baltimore, MD.
          [13 ] Newcastle University, Newcastle, United Kingdom.
          [14 ] University of Sydney, Sydney, Australia.
          [15 ] The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Canada.
          Article
          00007890-202004001-00009
          10.1097/TP.0000000000003136
          32301874
          7721693c-d745-4c86-9910-5f75e355b6d9
          History

          Comments

          Comment on this article